BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29449538)

  • 1. Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells.
    Krishnamoorthy J; Tenkerian C; Gupta J; Ghaddar N; Wang S; Darini C; Staschke KA; Ghosh A; Gandin V; Topisirovic I; Kristof AS; Hatzoglou M; Simos G; Koromilas AE
    Cell Death Dis; 2018 Feb; 9(3):254. PubMed ID: 29449538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress.
    Rajesh K; Krishnamoorthy J; Kazimierczak U; Tenkerian C; Papadakis AI; Wang S; Huang S; Koromilas AE
    Cell Death Dis; 2015 Jan; 6(1):e1591. PubMed ID: 25590801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies.
    Rajesh K; Papadakis AI; Kazimierczak U; Peidis P; Wang S; Ferbeyre G; Kaufman RJ; Koromilas AE
    Aging (Albany NY); 2013 Dec; 5(12):884-901. PubMed ID: 24334569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.
    Mounir Z; Krishnamoorthy JL; Wang S; Papadopoulou B; Campbell S; Muller WJ; Hatzoglou M; Koromilas AE
    Sci Signal; 2011 Sep; 4(192):ra62. PubMed ID: 21954288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC2 Balances AKT Activation and eIF2α Serine 51 Phosphorylation to Promote Survival under Stress.
    Tenkerian C; Krishnamoorthy J; Mounir Z; Kazimierczak U; Khoutorsky A; Staschke KA; Kristof AS; Wang S; Hatzoglou M; Koromilas AE
    Mol Cancer Res; 2015 Oct; 13(10):1377-88. PubMed ID: 26130148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRI coordinates translation by eIF2αP and mTORC1 to mitigate ineffective erythropoiesis in mice during iron deficiency.
    Zhang S; Macias-Garcia A; Velazquez J; Paltrinieri E; Kaufman RJ; Chen JJ
    Blood; 2018 Jan; 131(4):450-461. PubMed ID: 29101239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress.
    Rajesh K; Krishnamoorthy J; Gupta J; Kazimierczak U; Papadakis AI; Deng Z; Wang S; Kuninaka S; Koromilas AE
    Oncotarget; 2016 Aug; 7(32):51044-51058. PubMed ID: 27409837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.
    Koumenis C; Naczki C; Koritzinsky M; Rastani S; Diehl A; Sonenberg N; Koromilas A; Wouters BG
    Mol Cell Biol; 2002 Nov; 22(21):7405-16. PubMed ID: 12370288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
    Liu HJ; Lizotte PH; Du H; Speranza MC; Lam HC; Vaughan S; Alesi N; Wong KK; Freeman GJ; Sharpe AH; Henske EP
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting.
    Medvetz D; Sun Y; Li C; Khabibullin D; Balan M; Parkhitko A; Priolo C; Asara JM; Pal S; Yu J; Henske EP
    Mol Cancer Res; 2015 Jan; 13(1):50-62. PubMed ID: 25185584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications.
    Krishnamoorthy J; Rajesh K; Mirzajani F; Kesoglidou P; Papadakis AI; Koromilas AE
    Cell Cycle; 2014; 13(5):801-6. PubMed ID: 24401334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.
    Kovalenko A; Sanin A; Kosmas K; Zhang L; Wang J; Akl EW; Giannikou K; Probst CK; Hougard TR; Rue RW; Krymskaya VP; Asara JM; Lam HC; Kwiatkowski DJ; Henske EP; Filippakis H
    Cancer Res; 2021 Apr; 81(8):2086-2100. PubMed ID: 33593821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
    Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
    Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.
    Ferrer I; Mohan P; Chen H; Castellsague J; Gómez-Baldó L; Carmona M; García N; Aguilar H; Jiang J; Skowron M; Nellist M; Ampuero I; Russi A; Lázaro C; Maxwell CA; Pujana MA
    J Pathol; 2014 Jul; 233(3):247-57. PubMed ID: 24604753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex.
    Jin F; Jiang K; Ji S; Wang L; Ni Z; Huang F; Li C; Chen R; Zhang H; Hu Z; Zha X
    Hum Mol Genet; 2017 Jan; 26(2):407-419. PubMed ID: 28013293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells.
    Ju SM; Jo YS; Jeon YM; Pae HO; Kang DG; Lee HS; Bae JS; Jeon BH
    Int J Mol Med; 2017 Dec; 40(6):1957-1964. PubMed ID: 29039478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
    Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
    BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERK Signal-Modulated Protein Translation Promotes the Survivability of Dengue 2 Virus-Infected Mosquito Cells and Extends Viral Replication.
    Hou JN; Chen TH; Chiang YH; Peng JY; Yang TH; Cheng CC; Sofiyatun E; Chiu CH; Chiang-Ni C; Chen WJ
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28930151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.